Triple-negative breast cancer (TNBC) is defined by immunohistochemistry (IHC) as the lack of expression of estrogen receptor (ER), progesterone receptor (PR), and HER2 [3]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.